The US Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to EyeYon Medical for ...
ViaLase announced the first patient has been treated in its US-based Investigational Device Exemption (IDE) clinical trial ...
Ideaya Biosciences Inc. has submitted an IND application to the FDA for IDE-574, a KAT6/7 dual inhibitor with potential to treat hormone receptor-positive breast cancer and lung adenocarcinoma. A ...
"Mum, I'm in China." ...
It's not quite as cheap as we were finding it for over the peak sales period, granted. But this is still the best price ...
A bumper ten race card has been assembled for Pakenham this Saturday. Weather is fine, track is good (4) and the rail is in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback